Chemomab Therapeutics (CMMB) Earnings Date & Reports

Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CMMB is expected to report earnings to rise 233.33% to 0 cents per share on August 07

Chemomab Therapeutics CMMB Stock Earnings Reports

Q2'26

Est.

$-0.01

Q1'26

Beat

by $0.01

Q4'25

Missed

by $0.23

Q3'25

Missed

by $0.31

Q2'25

Beat

by $0.08

The last earnings report on May 14 showed earnings per share of 0 cents, beating the estimate of 0 cents. With 12.38K shares outstanding, the current market capitalization sits at 12.96M.

View a ticker or compare two or three

Compare

CMMB

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CMMB